Airway and Esophageal Stenting in Patients with Advanced Esophageal Cancer
Author Information
Author(s): Paganin Fabrice, Schouler Laurent, Cuissard Laurent, Noel Jean Baptiste, Becquart Jean-Philippe, Besnard Mathieu, Verdier Laurent, Rousseau Denis, Arvin-Berod Claude, Bourdin Arnaud
Primary Institution: Service de Pneumologie, GHSR, St Pierre, France
Hypothesis
The study aims to assess the efficacy and safety of scheduled and non-scheduled airway stenting in patients with esophageal stenting indications for advanced esophageal cancer.
Conclusion
Scheduled double stenting significantly improves symptoms and prognosis compared to emergency procedures.
Supporting Evidence
- Emergency procedures were associated with a poor prognosis compared to scheduled procedures.
- Overall mean survival was significantly shorter in emergency patients (6 weeks) than in scheduled patients (28 weeks).
- Scheduled double stenting improved symptoms in 95% of patients by day 7.
Takeaway
Doctors can help patients with advanced esophageal cancer breathe better by putting in special tubes, and doing it in a planned way works much better than doing it in an emergency.
Methodology
An observational study analyzing outcomes of airway stenting in patients with esophageal stenting indications, comparing emergency and scheduled interventions.
Potential Biases
Potential bias due to the observational nature of the study and lack of randomization.
Limitations
The study did not conduct a controlled trial for preventive stents and did not assess quality of life using a validated scoring system.
Participant Demographics
44 patients (37 males, 7 females) with a mean age of 58 years, all diagnosed with esophageal carcinoma.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website